Mesothelioma Survival Rate
Mesothelioma Life Expectancy Stage 1- Stage 1 patients have better prognosis compared to patients diagnosed in other stages of mesothelioma.
Approximately 41% -46% of phase 1 mesothelioma patients survive in two years, and 18% survive in five years.
By comparison, phase 4 patients typically stay for one year, with 7% surviving five years.
Survival rates are calculated from statistics of thousands of patients. The rate indicates the percentage of patients who are still alive some time after their diagnosis.
This measure describes what happened to a large group of patients in the past. It can only give you a general idea of what to expect from the individual tests right now.
Life expectancy for stage 1 mesothelioma depends on a number of factors, most notably the type of cancer cell and the age of the patient and the degree of severity.
Mesothelioma is a rare, complex disease, and all conditions are different.
Mesothelioma Life Expectancy Stage 1
Younger patients diagnosed with first-degree mesothelioma tend to have better prognosis and more treatment options than patients over 55 years of age.
In general, younger patients have a higher survival rate of five years due to their overall health and greater chance of becoming a candidate for surgery.
However, research shows that patients over the age of 70 receive the same benefits if they are not paid for surgeries such as pleurectomy and decortication.
The average age of a mesothelioma patient is 69, and about 8% of male patients aged 65 to 74 live for five years or more.
Currently, women in the same group have a five-year survival rate of 14.1%.
Mesothelioma Lung Cancer Survival Rate And Treatment
Stage 1 Treatment options for Mesothelioma
Surgery is the primary treatment for phase 1. Patients, however, radiation, chemotherapy or a combination of both will be performed during surgery to help improve long-term remission rates.
Talk to your doctor to learn how to choose a course of treatment because it may vary by institution.
Patients with local cancer have treatment options available. But it also depends on the overall health of the patient. Patients should be strong enough to manage an aggressive treatment plan.
Patients receiving multimodal treatment may live longer than mesothelioma prognosis.
There are two major surgical options for stage 1 pleural mesothelioma. One removes diseased tissue around the lungs, and the other removes the lung as well.
Which option is best based on how widespread the cancer is and how well the patient’s body can operate.
Pemetrexed (Alimta) and cisplatin are the most common chemotherapy treatments for mesothelioma.
Physicians can use chemotherapy alone or in combination with phase 1 surgery. After a patient recovers from surgery, he or she usually undergoes chemotherapy. The goal is to kill any cancer cells left in their body.
Traditionally doctors use radiation therapy after surgery to prevent recurrence. Applying radiation therapy after surgery can improve survival rates in certain patients with stage 1.
Clinical trials and Emerging Medicines
Many low-income patients who are otherwise healthy qualify for mesothelioma clinical examination.
These voluntary research studies test experimental drugs and treatments that have not yet been approved by the U.S. Food and Drug Administration for general use. Emerging mesothelioma treatments include immunotherapy, gene therapy and photodynamic therapy
Credits – https://www.asbestos.com/